Commission Actions

The Federal Trade Commission today finalized a consent order that resolves potential competitive harm stemming from Amgen Inc.’s acquisition of Horizon Therapeutics plc. As part of a nationwide...

Following Sanofi’s decision to terminate its proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s developmental drug to treat Pompe disease, the Federal Trade Commission moved to...

La Comisión Federal de Comercio (FTC, por su sigla en inglés) ha concluido una nueva regla para luchar contra dos tipos comunes de tácticas ilegales a las que se enfrentan los consumidores al comprar...

The Federal Trade Commission has finalized a new rule to fight two common types of illegal tactics consumers face when buying a car: bait-and-switch tactics and hidden junk fees. The new rule is...

The Federal Trade Commission is seeking to block Sanofi’s proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s therapy in development for treatment of Pompe disease. The Commission...

The Federal Trade Commission has obtained proposed orders against the operators of a wide-ranging scheme known as “The Sales Mentor” that made millions by falsely promising consumers that they could...

The Federal Trade Commission has issued an order approving the Horseracing Integrity and Safety Authority’s 2023 budget as submitted to the Commission. On March 27, 2023, the Commission adopted...